Clinical Trials Browser

Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Leukemia, Myelomonocytic, Acute

NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Phase 2 Withdrawn

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

NCT00460421 2014-12-05

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

Phase 1 Completed

27 enrolled 19 charts

LymphoidOther hematologic neoplasm

Leukemia, Stomatitis, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00640796 2014-04-24

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Phase 1 Completed

22 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00428558 2013-12-20

Timed-Sequential Induction in CBF-AML

Phase 3 Completed

200 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Phase 2 Terminated

51 enrolled

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00030355 2013-03-22

Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute

NCT00003673 2012-08-22

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Phase 2 Completed

55 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT00390715 2010-03-15

Treatment of Acute Myeloblastic Leukemia in Younger Patients

Completed

600 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00931138 2009-07-02

ALFA 9801

Phase 3 Completed

420 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00152139 2009-01-29

Stem Cell Transplantation for Patients With Hematologic Malignancies

Phase 3 Completed

33 enrolled

LymphoidMyeloidOther hematologic neoplasm

Hemoglobinuria, Paroxysmal, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Clinical Trials

FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

QuANTUM-WILD

A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias

The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia

Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?

The Efficacy of Allo-HSCT in ND HR-CBF-AML

QuANTUM-First

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Risk Stratification-directed Therapy for AML With t(8;21) /AML1-ETO+

A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

HINKL

LAUNCH

Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Timed-Sequential Induction in CBF-AML

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia

CMA-676 in Treating Older Patients With Acute Myeloid Leukemia in First Relapse

Treatment of Acute Myeloblastic Leukemia in Younger Patients

ALFA 9801

Stem Cell Transplantation for Patients With Hematologic Malignancies